Literature DB >> 7856733

Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells.

J R Bradley1, S Thiru, J S Pober.   

Abstract

We have used confocal immunofluorescence microscopy and immunogold electron microscopy to localize tumor necrosis factor (TNF) receptors in cultured human umbilical vein endothelial cells. The 75-kd receptor is largely expressed on the cell surface and undergoes endocytosis and transport to lycosomes through coated pits and coated vesicles. TNF may accelerate receptor clustering and internalization. The 55-kd receptor is expressed at much lower levels on the cell surface than the 75-kd receptor but is more abundant overall. It is predominantly localized to the Golgi apparatus and, to a lesser extent, cytoplasmic vacuoles. The cellular distribution of the 55-kd receptor is largely unaffected by TNF. These results have implications for TNF-mediated endothelial cell activation and for interactions between 75- and 55-kd TNF receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7856733      PMCID: PMC1870772     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

Review 1.  The pathophysiology of tumor necrosis factors.

Authors:  P Vassalli
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

Review 2.  Cytokines and endothelial cell biology.

Authors:  J S Pober; R S Cotran
Journal:  Physiol Rev       Date:  1990-04       Impact factor: 37.312

Review 3.  Culture of vascular endothelium.

Authors:  M A Gimbrone
Journal:  Prog Hemost Thromb       Date:  1976

4.  Molecular cloning and expression of a receptor for human tumor necrosis factor.

Authors:  T J Schall; M Lewis; K J Koller; A Lee; G C Rice; G H Wong; T Gatanaga; G A Granger; R Lentz; H Raab
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

5.  Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.

Authors:  M Brockhaus; H J Schoenfeld; E J Schlaeger; W Hunziker; W Lesslauer; H Loetscher
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

6.  Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor.

Authors:  H Loetscher; Y C Pan; H W Lahm; R Gentz; M Brockhaus; H Tabuchi; W Lesslauer
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

7.  A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins.

Authors:  C A Smith; T Davis; D Anderson; L Solam; M P Beckmann; R Jerzy; S K Dower; D Cosman; R G Goodwin
Journal:  Science       Date:  1990-05-25       Impact factor: 47.728

8.  Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration.

Authors:  M R Slowik; L G De Luca; W Fiers; J S Pober
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

9.  Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor.

Authors:  Y Nophar; O Kemper; C Brakebusch; H Englemann; R Zwang; D Aderka; H Holtmann; D Wallach
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

10.  Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors.

Authors:  M R Shalaby; A Sundan; H Loetscher; M Brockhaus; W Lesslauer; T Espevik
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

View more
  32 in total

Review 1.  Immunobiology of human vascular endothelium.

Authors:  J S Pober
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Staphylococcus aureus protein A activates TACE through EGFR-dependent signaling.

Authors:  Marisa I Gómez; Maghnus O Seaghdha; Alice S Prince
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

3.  TNF/TNFR1 signaling mediates doxorubicin-induced diaphragm weakness.

Authors:  Laura A A Gilliam; Jennifer S Moylan; Leonardo F Ferreira; Michael B Reid
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-19       Impact factor: 5.464

4.  The Membrane-Spanning Peptide and Acidic Cluster Dileucine Sorting Motif of UL138 Are Required To Downregulate MRP1 Drug Transporter Function in Human Cytomegalovirus-Infected Cells.

Authors:  Christopher B Gelbmann; Robert F Kalejta
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

5.  Caveolae participate in tumor necrosis factor receptor 1 signaling and internalization in a human endothelial cell line.

Authors:  Alessio D'Alessio; Rafia S Al-Lamki; John R Bradley; Jordan S Pober
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

6.  Characterization of DISC formation and TNFR1 translocation to mitochondria in TNF-α-treated hepatocytes.

Authors:  Hyun-Ae Eum; Raghuveer Vallabhaneni; Yinna Wang; Patricia A Loughran; Donna Beer Stolz; Timothy R Billiar
Journal:  Am J Pathol       Date:  2011-07-08       Impact factor: 4.307

7.  Upregulation of tumor necrosis factor receptor 1 and TNF-alpha converting enzyme during corneal wound healing.

Authors:  Tohru Sakimoto; Ai Yamada; Hitoshi Kanno; Mitsuru Sawa
Journal:  Jpn J Ophthalmol       Date:  2008-11-11       Impact factor: 2.447

8.  Association of Soluble TNFR-1 Concentrations with Long-Term Decline in Kidney Function: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Pavan K Bhatraju; Leila R Zelnick; Michael Shlipak; Ronit Katz; Bryan Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2018-10-04       Impact factor: 10.121

9.  DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF.

Authors:  Amanda L Gavin; Djemel Aït-Azzouzene; Carl F Ware; David Nemazee
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

10.  Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour.

Authors:  Ian Todd; Paul M Radford; Kelly-Ann Draper-Morgan; Richard McIntosh; Susan Bainbridge; Peter Dickinson; Lama Jamhawi; Marios Sansaridis; Mary L Huggins; Patrick J Tighe; Richard J Powell
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.